08 January 2018
Aamal Company Q.P.S.C., one of the region’s fastest growing diversified companies –and its fully owned subsidiary, Ebn Sina Medical – announced a distribution agreement with Turkish Company CinnaGen...
06 January 2018
Turkish pharmaceutical firm CinnaGen has signed a $6m deal with Qatar’s leading drug company Ebn Sina Medical on Wednesday. Ferhat Farsi, Chief Executive Officer, CinnaGen, speaking at a signing...
Subscribe to Ferhat Farsi